Mechanoactivation has attracted considerable
attention in the pharmaceutical
sciences due to its ability to generate amorphous materials and solid-state
synthetic products without the use of solvent. Although some studies
have reported drug degradation during milling, no studies have systematically
investigated the use of mechanoactivation in predicting drug degradation
in the solid state. Thus, this work explores the autoxidation of drugs
in the solid state by comilling amorphous mifepristone (MFP):polyvinylpyrrolidone
vinyl acetate (PVPVA) and amorphous olanzapine (OLA):PVPVA. MFP was
amorphized by ball milling and OLA by quench cooling techniques. Subsequently,
comilling the amorphous drugs in the presence of a 10-fold weight
ratio of PVPVA (the excipient containing reactive free radicals) was
performed at several milling frequencies to identify the kinetics
of mechano-autoxidation over milling durations. Overall, milling led
to the degradation of up to 5% drug in the solid state. The autoxidation
mechanism was confirmed by performing a stress study in the solution
at 50 °C for 5 h, by using a 10 mM azo-bis(isobutyronitrile)
(AIBN) as a stressing agent. By deconvoluting the effect of milling
frequency and the energy on the extent and kinetics of milling-induced
autoxidation of amorphous drugs, it was possible to fit an extended
Arrhenius model that allowed extrapolation of mechanoactivated degradation
rates (K
m) to zero milling frequencies.
Further, the autoxidation rates of drugs stored at high temperatures
were observed to follow an Arrhenius behavior. A good degree of agreement
was observed between the model predictions obtained by mechanoactivation
(K
m) to the reaction rates observed under
accelerated temperatures. Additionally, the impact of adding an antioxidant
(e.g., butylated hydroxytoluene) to the mixture during comilling was
also examined. This study can be helpful in evaluating the stability
of amorphous solids stored in accelerated (non-hermetic) conditions,
in screening solid-state autoxidation propensity of drugs, and for
the rational selection of antioxidants.